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Cellular Maturation Defects in Bruton’s Tyrosine
Kinase-Deficient Immature B Cells Are Amplified by
Premature B Cell Receptor Expression and Reduced by
Receptor Editing1
Sabine Middendorp and Rudolf W. Hendriks2
In the mouse, Bruton’s tyrosine kinase (Btk) is essential for efficient developmental progression of CD43CD2 large cycling into
CD43CD2 small resting pre-B cells in the bone marrow and of IgMhigh transitional type 2 B cells into IgMlow mature B cells
in the spleen. In this study, we show that the impaired induction of cell surface changes in Btk-deficient pre-B cells was still
noticeable in  immature B cells, but was largely corrected in  immature B cells. As  gene rearrangements are programmed
to follow  rearrangements and  expression is associated with receptor editing, we hypothesized that the transit time through the
pre-B cell compartment or receptor editing may affect the extent of the cellular maturation defects in Btk-deficient B cells. To
address this issue, we used 3-83 transgenic mice, which prematurely express a complete B cell receptor and therefore manifest
accelerated B cell development. In Btk-deficient 3-83 mice, the IgM B cells in the bone marrow exhibited a very immature
phenotype (pre-BCRCD43CD2) and were arrested at the transitional type 1 B cell stage upon arrival in the spleen. However,
these cellular maturation defects were largely restored when Btk-deficient 3-83 B cells were on a centrally deleting background
and therefore targeted for receptor editing. Providing an extended time window for developing B cells by enforced expression of
the antiapoptotic gene Bcl-2 did not alter the Btk dependence of their cellular maturation. We conclude that premature B cell
receptor expression amplifies the cellular maturation defects in Btk-deficient B cells, while extensive receptor editing reduces these
defects. The Journal of Immunology, 2004, 172: 1371–1379.
T he generation of B cells from progenitor cells is a com-plex process involving the transit of cells through severalcritical developmental stages. Developing B cell precur-
sors in the bone marrow pass several checkpoints at which they are
subject to choices between survival, proliferation, or cell death
dependent on the presence of functional Ig H and L chains. Ex-
pression of the pre-B cell receptor (pre-BCR3) complex, comprised
of  H chain, the VpreB and 5 surrogate L chain (SLC) proteins,
and the Ig/CD79a and Ig/CD79b signaling components, is es-
sential for IL-7-dependent proliferative expansion of cytoplasmic
 H chain positive (c) pre-B cells (1, 2). In addition, the pre-
BCR triggers the inhibition of further H chain rearrangements,
known as allelic exclusion, as well as drastic changes of pre-B cell
surface phenotype. Furthermore, the down-regulation of prolifer-
ation in large cycling pre-B cells and the induction of progression
into small resting pre-B cells, in which Ig L chain rearrangement
is initiated, are regulated by the pre-BCR. Signaling proteins in-
volved in the downstream pathway of the pre-BCR include the
Lyn, Syk, and Bruton’s tyrosine kinase (Btk) tyrosine kinases,
phosphoinositide 3-kinase (consisting of p85 and p110 subunits),
the B cell linker protein BLNK/SLP-65 and the phospholipase
C2. Cytoplasmic  pre-B cells of mice deficient for the pre-
BCR components 5, VpreB, membrane  H chain, Ig, or Ig or
the pre-BCR signaling molecules Syk or p85 do not enter the
expansion phase (reviewed in Ref. 3).
In contrast, absence of the pre-BCR signaling proteins Btk and
BLNK/SLP-65 was shown to be associated with defects in cell
cycle exit, resulting in a high incidence of pre-B cell tumors (4–8).
In SLP-65-deficient mice, and even more so in Btk/SLP-65 double
mutant mice, large cycling pre-B cells are trapped in a positive
feedback loop as they are arrested in development and cannot ef-
ficiently down-regulate pre-BCR expression, which signals for
proliferation (7–9). Mutations in the Btk gene result in X-linked
agammaglobulinemia in humans and x-linked immunodeficiency
(xid) in the mouse (10). X-linked agammaglobulinemia is charac-
terized by a severe arrest of B cell development at the pre-B cell
stage, and consequently peripheral B cells and Abs of all sub-
classes are almost completely absent. xid mice manifest a milder
phenotype associated with an impairment of peripheral B cell mat-
uration, without a major early block in B cell development in the
bone marrow (BM). As a result, peripheral B cells are present in
lower numbers and serum IgM and IgG3 levels are low.
Recently, we have shown that pre-B cell differentiation in Btk-
deficient mice is impaired (5, 8). During the transition of large
cycling into small resting pre-B cells, Btk-deficient mice fail to
efficiently modulate the expression of SLC, the metallopeptidase
BP-1, the adhesion molecule CD2, the IL-2R CD25, MHC class II,
and the membrane sialoglycoprotein CD43. Moreover, in an anal-
ysis of the kinetics of pre-B cell differentiation in vivo, Btk-defi-
cient cells manifested a specific developmental delay within the
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small pre-B cell compartment of 3 h when compared with wild
type (WT) cells. Despite the similar absolute numbers of immature
B cells generated in both mice, Btk immature B cells are phe-
notypically different from WT immature B cells. The impaired
induction of cell surface changes in Btk-deficient small pre-B cells
is still noticeable at the immature B cell stage, in particular with
regard to the expression levels of BP-1 and CD2 (5). In this re-
spect, we now found that  L chain-positive immature B cells are
more affected by the lack of Btk than  L chain-positive immature
B cells. Given that  gene rearrangements in pre-B cells are pro-
grammed to occur24 h later than  rearrangements, it is possible
that the transit time through the pre-B cell compartment may affect
the differentiation defects in Btk-deficient B cells. Alternatively, as
 L chain expression is often associated with receptor editing, the
BCR signaling events that induce receptor editing may also facil-
itate cellular maturation.
To distinguish between these possibilities, we modified the ki-
netics of B cell development by crossing Btk-deficient mice with
3-83-transgenic (Tg) mice, which carry a BCR transgene con-
sisting of prerearranged  and  H chain genes as well as a  L
chain gene (11). Because the expression of the 3-83 transgene
is under the control of the Ig H chain enhancer, the 3-83 BCR
is expressed from the pro-B cell stage onward. The 3-83 BCR
specifically recognizes MHC class I molecules of the H2-Kk/b al-
lotype (11), and thus reflects an innocuous BCR in mice that have
an H2-Kd background. Mice with such a nonautoreactive back-
ground (also called nondeleting mice) contain a virtually mono-
clonal B cell population. Since the prematurely expressed 3-83
BCR is able to promote B cell development, it appears that this
BCR can functionally replace the pre-BCR and consequently B
cell development is accelerated (11–13). In contrast, when the
3-83 BCR is expressed in mice of the MHC class I H2-Kb
background, all B cells generated are autoreactive and are targeted
for continued L chain gene rearrangement, a process known as
receptor editing, to survive (14–16). B cells in these centrally de-
leting mice are delayed in the small pre-B cell stage due to the
receptor editing process (17, 18).
By crossing Btk-deficient mice with 3-83 Tg mice on a non-
deleting or a deleting MHC class I background, we were able to
study the effects of Btk on cellular maturation of B cell precursors
undergoing accelerated development or receptor editing, respec-
tively. Furthermore, we tested whether providing an extended time
window per cell for the induction of cell surface marker changes,
by the enforced expression of the Bcl-2 apoptosis inhibitor, would
facilitate cellular maturation in Btk-deficient pre-B cells.
Materials and Methods
Mice and genotyping
Btk-deficient mice (19) were crossed onto the C57BL/6 background for
more than eight generations. 3-83 mice (11) were on a nondeleting
B10.D2 background. Endogenous Btk WT alleles were identified as de-
scribed previously (5). Expression of a 3-83 was identified by a 3-83 V
forward primer (5-CAGCTTCCTGCTAATCAGTGCC-3) and a 3-83
J2 reverse primer (5-TGGTCCCCCCTCCGAACGTG-3) (11). MHC I
background was determined by FACS analysis of peripheral blood samples
by using mAbs against H2-Kb and H2-Kd (below). The presence of the
E-2–22 Bcl-2 transgene was evaluated by PCR (20).
Flow cytometric analysis
Preparations of single-cell suspensions, standard and intracellular flow cy-
tometry, and determination of -galactosidase activity by loading cells
with fluorescein--D-galactopyranoside substrate have been described pre-
viously (5, 19, 21). The hybridomas LM34 (anti-SLC; (22)) and PB493
(anti-AA4.1; (23)) were kindly provided by A. Rolink (University of Basel,
Basel, Switzerland). The anti-3-83 hybridoma 54-1 (15) was kindly pro-
vided by D. Nemazee (The Scripps Research Institute, La Jolla, CA). Hy-
bridoma Abs were purified using protein G columns and conjugated to
biotin according to standard methods or used unlabeled in combination
with PE- or allophycocyanin-conjugated goat anti-rat secondary Abs. The
following mAbs were obtained from BD PharMingen (San Diego, CA):
FITC-conjugated anti-CD21 (7G6), anti-CD22 (Cy34.1), and anti-CD62L
(MEL-14); PE-conjugated anti-MHC class II (M5/114), anti-CD19 (1D3),
anti-IgM (R6-60.2), anti-CD23 (B3B4), and anti-H2-Kd (SF1–1.1); PerCP-
and allophycocyanin-conjugated anti-B220 (RA3-6B2) and anti-CD19
(1D3); biotinylated anti-Ly6C (ER-MP20), anti-CD23 (B3B4), and anti-
H2-Kb (AF6-88.5). Unlabeled anti-CD21 (7G6; BD PharMingen) was bi-
otinylated according to standard methods and FITC-conjugated anti-IgD
(11–26) was obtained from Southern Biotechnology Associates (Birming-
ham, AL). In vivo 5-bromo-2deoxyuridine (BrdU) labeling and detection
and all other mAbs used were described previously (5).
IL-7-driven BM cultures
Primary pre-B cell BM cultures and determination of IL-7-dependent prolif-
erative responses of total BM cells have been described previously (5, 20).
Results
In Btk-deficient mice,  and  immature B cells show
differences in cellular maturation
During the progression of large cycling into small resting c H
chain-positive pre-B cells, Btk-deficient mice manifest defective
down-regulation of BP-1, CD43, and SLC and impaired up-regu-
lation of CD2, CD25, and MHC class II, as shown by flow cyto-
metric analysis (Fig. 1, A and B and Refs. 5 and 8). In this study,
we have also included the mAb PB493 recognizing the comple-
ment component C1q-like receptor C1qRp, also known as AA4.1
(24). This marker is expressed on all B lineage cells in the BM, but
in the spleen only on those B cells that reflect recently immigrated
immature B cells (23). In Btk-deficient mice, we found increased
proportions of PB493 cells in the B220IgM B cell precursor
compartment when compared with Btk mice (Fig. 1B), indicating
that the modulation of expression of this marker is also Btk de-
pendent. As shown in Fig. 1B, the proportions of cells that express
 H chain in their cytoplasm within the surface IgM B cell pre-
cursor fractions are similar in Btk-deficient and WT mice.
We previously found that the inefficient induction of cell surface
phenotype changes in Btk-deficient mice was still noticeable in
immature B cells, in particular for BP-1 and CD2 (5). In a separate
analysis of  and  L chain-positive B220lowIgM immature B
cells, we now observed that elevated expression of BP-1 was more
pronounced in Btk-deficient  immature B cells when compared
with  cells. Reduced expression of CD2, MHC class II and
CD25 was limited to  immature B cells, while  immature B
cells manifested essentially normal surface expression of these
markers (Fig. 1C and data not shown).
In summary, these findings indicate that in Btk-deficient mice
the impaired modulation of developmentally regulated markers in
small pre-B cells results in very immature phenotype of  B cells
in the BM, while  B cells appear less affected.
Btk-deficient 3-83 mice show amplified B cell differentiation
defects
We hypothesized that the observed differences in surface pheno-
type between Btk-deficient  and  immature B cells may re-
flect the programmed sequential activation of the  and  loci. In
pre-B cells,  gene rearrangements are programmed to occur 24
h later than  rearrangements, and thus  immature B cells have
resided for a longer period of time within the small pre-B cell
compartment (25, 26). Therefore, the extent of the differentiation
defects in Btk-deficient B cells may correlate with the rate of tran-
sit through the pre-B cell compartment. To directly test this hy-
pothesis, we crossed Btk-deficient mice with 3-83 Tg mice,
which prematurely express a prerecombined BCR that functionally
replaces the pre-BCR. As a result, B cells spend little or no time in
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the small pre-B cell stage and B cell development is accelerated
significantly.
Total BM cell suspensions from Btk and Btk 3-83 mice
were analyzed by flow cytometry (Fig. 2). Irrespective of the pres-
ence of Btk, the B lineage compartment in 3-83 mice mainly
consisted of B220low immature B cells that were c and also
expressed IgM on the cell surface. However, the B220low imma-
ture B cell fraction present in Btk 3-83 mice contained very
few IgD B cells (2%) when compared with Btk 3-83 mice
(23% IgD cells; Fig. 2A). Furthermore, the BM of Btk 3-83
mice did not contain mature B220highIgDhigh recirculating B cells.
Next, the expression pattern of several developmental markers was
analyzed in the B220lowIgM immature B cell compartment. In
WT mice, immature B cells did not express SLC, BP-1, and CD43,
were low for PB493 and CD25, and positive for CD2 and MHC
class II (Fig. 1C and Ref. 5). However, due to the expression of the
3-83 transgene in WT mice, the B220lowIgM compartment
had a more immature phenotype: CD43/low, PB493high, CD25low,
and CD2low. Notably, Btk-deficient 3-83 mice showed signifi-
cantly impaired B cell maturation, as the B220lowIgM B cells
expressed substantial levels of CD43 and SLC and lacked expres-
sion of CD2 and CD25 (Fig. 2B), when compared with their Btk
3-83 littermates. The expression of MHC class II on
B220lowIgM B cells did not appear to be affected by the prema-
ture BCR expression.
These results indicate that a prematurely expressed 3-83 BCR
was only partially able to functionally replace the pre-BCR, as the
modulation of expression of developmentally regulated markers
was impaired. In Btk-deficient 3-83 mice, this defect was even
stronger, as evidenced by an almost complete absence of down-
regulation of CD43 and SLC and induction of CD2 and CD25 in
IgM B cells in the BM.
Btk-deficient 3-83 mice manifest a severe reduction of B cell
numbers in the spleen
Total splenic cell suspensions from Btk and Btk 3-83 mice
were analyzed by flow cytometry and compared with non-Tg lit-
termates. The xid phenotype of Btk-deficient mice is characterized
by a specific deficiency of mature IgMlowIgDhigh B cells in the
spleen, resulting in a reduction of the B cell numbers by 50%
(19, 27, 28). As previously described (16), expression of the
3-83 transgene on a WT background only marginally affected
the splenic B cell numbers. Surprisingly, we observed a profound
reduction of the size of the splenic B cell population in Btk
3-83 mice, as 2  106 B cells were present compared with
20  106 B cells in Btk 3-83 mice (Fig. 3A and Table I).
This severe reduction of splenic B cells in Btk 3-83 mice
may reflect a reduced survival capacity of Btk 3-83 B cells in
the BM or in the spleen. Alternatively, it is possible that the ab-
sence of Btk affects the signals transmitted by the 3-83 BCR in
FIGURE 1. Phenotypic characterization of the B lineage compartment
in BM of Btk and Btk mice. A, BM lymphoid cells were electronically
gated on the basis of forward and side scatter and expression of B220 vs
IgM is plotted. B, B220lowIgM pro- and pre-B cells were gated and ex-
pression of several developmentally regulated markers is shown as histo-
grams. Numbers indicate percentage of cells positive for the indicated
marker and plots are representative for 20 mice of each genotype. C,
B220lowIgM immature B cells were gated and expression of Ig and BP-1
or CD2 is shown. Numbers indicate percentage of BP-1- or CD2-positive
cells within  or  immature B cells. Plots are representative for four
mice of each genotype.
FIGURE 2. Phenotypic characterization of the BM B cell compartment
in Btk and Btk 3-83 mice. A, BM lymphoid cells were gated and
plotted for B220 and c (upper part). B220high and B220low cells were
separately gated and IgM/IgD profiles of both populations are shown
(lower part). B, The B220low B cell population was further analyzed for
expression of various developmentally regulated markers, as shown in the
histograms. The percentages of cells within the indicated gates or quadrants
are given. Data represent six to eight mice analyzed per genotype.
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such a way that these B cells are considered autoreactive and are
therefore deleted. Autoreactive B cells down-regulate surface IgM
expression and are subject to receptor editing at the immature B
cell stage in the BM (12, 14, 16, 29). However, flow cytometric
analyses did not provide evidence for autoreactive characteristics
of Btk 3-83 B cells. The B cells were IgMhigh and did not edit
their BCR, as they were mainly positive for the anti-idiotypic Ab
54-1 and  L chain, both in BM and in spleen (Figs. 2, A and B,
and 3, A and B).
The residual B cell population in Btk 3-83 spleens mainly
consisted of immature IgMhighIgD/low that were CD21 and
CD23, indicating that these B cells were recent immigrants from
the BM arrested at the stage of transitional type 1 (T1) B cells (Fig.
3B and Table I; Refs. 30 and 31). This was confirmed by an eval-
uation of additional developmentally regulated cell surface mark-
ers. As shown in Fig. 3C, splenic B cells in Btk and Btk non-Tg
mice and in Btk 3-83 mice are largely CD43, PB493,
CD2high, CD22high, and CD62L. In contrast, Btk 3-83 B
cells showed significantly increased expression of the immature
markers CD43 and PB493 and reduced expression of the matura-
tion markers CD2, CD22, and CD62L. Taken together, only a
small number of peripheral B cells reached the stage of T2 cells
(IgMhigh, IgD, CD21, CD23; Refs. 30 and 31) and mature
IgMlow IgD cells were virtually absent (Fig. 3 and Table I). The
expression levels of SLC, BP-1, CD25, and MHC class II were
similar in the four groups of mice (data not shown). Despite the
low B cell numbers and their immature phenotype, splenic archi-
tecture was not seriously disturbed in Btk 3-83 mice as B/T
cell separation was normal and small regions with marginal zone
B cells and macrophages were present, as analyzed by immuno-
histochemistry (data not shown).
In summary, these findings show that peripheral Btk 3-83 B
cells differentiated normally. By contrast, Btk-deficient 3-83
mice exhibited a severe reduction of B cell numbers in the spleen,
whereby the residual B cells present were Id positive and mainly
had an immature T1 surface phenotype.
Btk-deficient 3-83 B cells are rapidly deleted upon arrival in
the spleen
The finding that the proportions of B220 B lineage cells in BM
of Btk 3-83 mice were not significantly different from those in
Btk 3-83 mice (5.5%  1.2 and 4.5%  1.8, respectively)
implied that the numbers of B cells generated in the BM of Btk
and Btk 3-83 mice were comparable. Therefore, the severe
decrease in splenic B cell numbers in Btk 3-83 mice may be
caused by defective homing of immature B cells from the BM into
the spleen or alternatively by rapid deletion upon arrival in the
spleen. To distinguish between these two possibilities, we inves-
tigated the competition between Btk and Btk 3-83 B cells in
vivo. We analyzed heterozygous Btk/ female mice, which have
the BtklacZ allele on the active X chromosome in 50% of all
cells, due to random X chromosome inactivation. However, when
FIGURE 3. Phenotypic characterization of B cell compartments in spleens of Btk and Btk non-Tg and 3-83 mice. A, Splenic lymphoid cells were
gated and IgM/IgD expression profiles are plotted. B, B220 cells were gated and analyzed for expression profiles of 54-1/Ig (upper part) and CD21/CD23
(lower part). C, B220 cells were gated and analyzed for the expression of CD43 and CD2 on IgM cells and expression of PB493, CD22, and CD62L
on CD19 cells. A–C, The percentages of cells within the indicated gates or quadrants are given; data represent three to eight mice analyzed per genotype.
D, Expression of lacZ in splenic B cells of Btk/ non-Tg and 3-83 heterozygous female mice. Splenic B cells were gated using IgM and IgD expression
profiles, and LacZ expression in these populations was compared with lacZ expression in ER-MP20high BM monocyte precursor cells. Mean percentages 
SD values of lacZ-positive cells within the indicated gates were plotted and significance between non-Tg and 3-83 mice was evaluated by Student’s t
test (, p  0.01). Data represent four to five mice analyzed per genotype. E, BrdU incorporation in spleen after a single dose of BrdU injection in Btk
and Btk 3-83 mice. The absolute number of BrdU cells was calculated within the B220IgMhighIgD/low B cell population. Mean values of two to
six mice per time point were plotted.
1374 KINETICS OF B CELL DEVELOPMENT AND Btk DEFICIENCY
in these mice B lineage cells reach a differentiation stage in which
Btk is required, the Btk acZ cells will be arrested in development
and consequently the proportions of Btk lacZ cells decrease be-
low 50% (19).
BM and spleen cell suspensions from Btk/ non-Tg and
3-83 mice were compared for the proportions of lacZ-express-
ing cells by using fluorescein-di--galactopyranoside as a sub-
strate in conjunction with surface labeling of B220, IgM, and IgD.
Irrespective of the presence of the 3-83 transgene, the spleens of
Btk/ mice contained detectable fractions of lacZ B cells, in-
dicating that homing of B cells from the BM into the spleen was
not altered by the expression of the 3-83 BCR (Fig. 3D). More-
over, the immature IgMIgD fraction in 3-83 mice contained
50% lacZ cells, showing that Btk-deficient B cells accumulated
due to the differentiation arrest. Consistent with previous findings
(19), a dramatic selection against BtklacZ cells occurred during
B cell differentiation in the spleen: the immature IgMIgD/low
cell populations still contained substantial proportions of
BtklacZ cells, whereas in the IgMlowIgDhigh mature B cell pop-
ulation these cells were virtually absent (Fig. 3D).
To confirm that Btk-deficient 3-83 B cells were deleted upon
arrival in the spleen, we performed BrdU-labeling experiments in
vivo. Btk or Btk 3-83 mice were injected with a single dose
of BrdU, which is incorporated into the DNA of large cycling
pre-B cells in the BM (17, 25, 32). The amount of BrdU incorpo-
ration was found to be similar in BM B cells from both types of
mice (data not shown). One, 2, or 3 days after BrdU injection,
spleen cell suspensions were stained for B220, IgM, and IgD in
conjunction with intracellular staining for BrdU. B220IgMhigh
IgD/low cells were gated and the absolute number of BrdU cells
was calculated. We found that in Btk 3-83 mice the number of
BrdUIgMhighIgD/low B cells accumulated over time (Fig. 3E).
In contrast, the number of BrdU cells in Btk 3-83 mice re-
mained low, indicating that the number of cells arriving in the
spleen was similar to the number of cells that was deleted.
From these findings, we conclude that Btk 3-83 immature B
cells migrated normally from the BM into the spleen, but upon
arrival these B cells did not further differentiate and were deleted
within 24 h.
Btk 3-83 BM B cells show deficient developmental
progression in vitro
To investigate whether the inefficient 3-83 BCR-mediated in-
duction of cell phenotype changes in Btk B cells in vivo were
paralleled in BM cultures in vitro, IL-7-driven BM cultures were
performed as described previously (5, 33). Total BM cells from
Btk and Btk non-Tg and 3-83 mice were cultured in the
presence of 100 U/ml IL-7 for 5 days and proliferation was quan-
tified in [3H]thymidine incorporation experiments (Fig. 4A). Con-
sistent with our previous report (5), Btk non-Tg BM cultures
showed significantly higher proliferative responses to IL-7 when
compared with Btk cultures. Proliferative responses to IL-7 were
similar in Btk and Btk 3-83 BM cultures. To evaluate de-
velopmental progression in vitro, BM cells were cultured in the
presence of IL-7 for 5 days and recultured in the absence of IL-7
on S17 stromal cells for 48 h. As previously described (5), under
these conditions, WT pre-B cells differentiated into immature B
cells expressing CD2, IgM, and IgD, whereas Btk-deficient pre-B
cells were not able to efficiently up-regulate CD2 and IgD expres-
sion (Fig. 4B). In BM cultures from Btk 3-83 mice, expression
of CD2 and IgD was induced on the B cells, but Btk 3-83 B
cells were not able to up-regulate CD2 and IgD upon IL-7 with-
drawal (Fig. 4B).
These data show that also under in vitro conditions, develop-
mental progression of Btk 3-83 BCR-expressing B cells is
Table I. Absolute number of B cell subsets in spleen







Btk 17 37.8 2.4 2.1 0.2 5.5 0.5 25.0 2.0
Btk 15 16.1 1.5 1  107 2.2  0.3 5.5 0.8 5.8  0.6
3-83 Btk nondeleting 19 16.0 1.2 1.3 0.2 6.3 0.8 6.9  0.6
3-83 Btk nondeleting 14 1.2  0.1 1  1010 0.5  0.1 0.2 0.0 0.1  0.0
3-83 Btk deleting 4 4.0  1.4 0.7 0.3 1.0 0.4 1.8  0.8
3-83 Btk deleting 7 2.1  1.0 NS 0.2 0.1 0.4 0.2 1.0  0.6
3-83/Bcl-2 double Tg Btk nondeleting 3 28.3 2.8 0.7 0.2 11.7 0.8 11.3  2.6
3-83/Bcl-2 double Tg Btk nondeleting 3 15.8 4.1 0.05 5.3  1.3 6.0 1.3 1.9  0.7
a Absolute number as mean  SEM (106).
b Values of P for the difference in absolute numbers of B220 cells compared with Btk littermates, determined by Student’s t test.
c T1, T2, and mature B cell subsets of B220 cells.
FIGURE 4. Analysis of IL-7-driven BM cultures from Btk and Btk
non-Tg and 3-83 mice. A, Proliferative responses of total BM cells as
determined by [3H]thymidine incorporation after 5 days of culture with or
without IL-7. Means  SD values for two to four mice per genotype were
plotted. B, After 5 days of culture with IL-7, cells were washed and re-
cultured for 48 h on S17 stromal cells in the absence of IL-7. Expression
profiles of B220/CD2 on live cells (upper part) and of IgM/IgD on B220
gated cells (lower part) are shown. Data are representative of five mice
analyzed per group.
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impaired, as is clear from low CD2 and IgD induction upon IL-7
withdrawal.
Receptor editing can compensate for developmental defects in
Btk 3-83 mice
To investigate whether receptor editing and the resulting delay at
the small pre-B cell stage in the BM could compensate for the
cellular maturation defects in Btk 3-83 mice, we targeted
3-83 B cells for receptor editing by crossing the 3-83 mice
onto a centrally deleting MHC class I background.
When we analyzed the BM of Btk and Btk 3-83 centrally
deleting mice by flow cytometry, we found that B220c cells
had down-regulated surface expression of IgM and CD19 and were
also low for the anti-idiotypic Ab 54-1, confirming the autoreactive
nature of the B cell compartment (Fig. 5A). The expression profiles
of developmentally regulated surface markers on B220lowc
cells in Btk 3-83 mice were similar to those found in non-Tg
WT immature B cells, i.e., SLCCD43CD2 (Fig. 5B). Remark-
ably, Btk 3-83 centrally deleting mice manifested an almost
complete correction of marker expression profiles when compared
with Btk 3-83 nondeleting mice: expression of SLC and CD43
was low and CD2 was present on a large fraction of cells (cf Figs.
5B and 2B). Therefore, we conclude that extended receptor editing
in the BM could almost completely correct the Btk-dependent de-
fects in B cell surface marker expression of 3-83 immature B
cells in the BM.
The spleens of 3-83-deleting mice contained very few B
cells, irrespective of the presence of Btk (Fig. 5C and Table I). As
a result, the total splenic B cell numbers in Btk 3-83 mice
were comparable on the nondeleting (1.2 106) and the deleting
MHC class I background (2.1  106; Table I). Those Btk and
Btk B cells present in the spleen of 3-83-deleting mice have
essentially lost 54-1 expression and show increased Ig  L chain
usage due to receptor editing (cf Figs. 5C and 3B). Remarkably, we
found that the residual B cells in the spleens of Btk and Btk
3-83-deleting mice had similar IgM/IgD and CD21/CD23 pro-
files (Fig. 5C), had similar expression levels of CD43, CD2, CD19,
and MHC class II, and were negative for SLC, BP-1, and CD25
(Fig. 5D and data not shown).
In summary, these data indicate that both Btk and Btk
3-83 B cells that were targeted for receptor editing have reduced
maturation defects when compared with Btk and Btk 3-83 B
cells on a nondeleting background. The expression of the devel-
opmentally regulated markers is completely corrected in edited
Btk 3-83 peripheral B cells, while in edited Btk 3-83 cells
the cellular maturation defects are comparable to those found in
non-Tg Btk B cells (Figs. 1 and 2).
Bcl-2 overexpression does not rescue Btk-dependent marker
modulation
We investigated whether the observed correction of marker mod-
ulation in editing Btk-deficient pre-B cells was dependent on ad-
ditional signals that follow the engagement of an autoreactive BCR
with autoantigen or alternatively resulted from the developmental
delay in the small pre-B cell stage associated with receptor editing.
To this end, Btk-deficient mice were crossed with Tg mice that
express the antiapoptotic Bcl-2 gene, which is assumed to provide
an extended time window per cell for Ig L chain rearrangement
(34). When we compared the B cell compartment in Btk and
Btk E-Bcl-2 Tg mice, we found that enforced expression of
Bcl-2 only slightly improved cellular maturation of pre-B and im-
mature B cells in the absence of Btk (cf Figs. 6, A and B, and 1).
Next, we investigated whether Bcl-2 expression could rescue the
developmental defects observed in Btk 3-83 nondeleting mice.
Therefore, Btk-deficient 3-83 mice were crossed with E-Bcl-2
Tg mice on a non-deleting MHC class I background. Overexpres-
sion of Bcl-2 did not rescue cellular maturation of Btk 3-83
immature B cells, as expression of SLC, BP-1, CD43, and PB493
was not down-regulated and expression of CD25, CD2, and IgD
was hardly induced (Fig. 6C and data not shown). The BM B cells
in Btk and Btk 3-83/Bcl-2 double Tg mice were all 54-1
(data not shown) and did not show increased  usage (0.3%).
The absolute number of splenic B cells in Btk 3-83/Bcl-2 dou-
ble Tg mice was corrected when compared with Btk 3-83 mice
and the B cells in the spleen were not arrested at the T1 stage (Fig.
6D and Table I). The B cells in Btk 3-83/Bcl-2 double Tg spleens
were largely IgMhighCD21CD23, indicating an almost complete
block in B cell development from transitional stage T2 into the mature
B cell compartment. Compared with their Btk 3-83 single Tg
littermates, a larger fraction of splenic B cells in Btk 3-83/Bcl-2
FIGURE 5. Phenotypic characterization of the B cell compartment in
Btk and Btk 3-83 mice on a centrally deleting background. A and B,
BM lymphoid cells were gated and plotted for the expression of B220 and
c. B220c cells were gated and plotted for IgM/IgD and 54-1/Ig
expression profiles (A) and analyzed for the expression of the indicated
markers (B). C, Splenic lymphoid cells were gated and analyzed for IgM/
IgD expression and for CD21/CD23 and 54-1/Ig expression profiles on
B220 gated cells. D, Expression pattern of the indicated markers on
B220 cells. The percentages of cells within the indicated gates or quad-
rants are given. Data represent 8–20 mice analyzed per genotype.
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double Tg mice differentiated into CD21CD23 B cells (80%
compared with 50%, respectively; Fig. 6D).
From these data, we conclude that an extended time window per
cell for pre-B cell differentiation by enforced expression of Bcl-2
was not sufficient to rescue the maturation defects in Btk-deficient
pre-B cells. However, the expression of Bcl-2 rescued the periph-
eral B cell arrest at the T1 stage in Btk 3-83 mice and con-
sequently B cells were arrested at the T2 stage, as in non-Tg
Btk-deficient mice.
Discussion
Btk is essential at two distinct steps in B cell development in the
mouse 1) at the developmental progression of CD43CD2 large
cycling into CD43CD2 small resting pre-B cells and 2) at the
checkpoint for selection of immature IgMhigh T2 cells into the pool
of long-lived IgMlow mature B cells (5, 19, 28, 30, 31, 35, 36). In
this report, we show that in Btk-deficient mice premature expres-
sion of the 3-83 BCR amplifies the cellular maturation defects
in immature B cells in the BM and results in an arrest of peripheral
B cell development at the transition of T1 into T2 cells in the
spleen. Both defects are largely restored when Btk-deficient
3-83 mice are crossed onto a centrally deleting background
where the B cells were targeted for receptor editing. In contrast,
enforced expression of the apoptosis inhibitor Bcl-2, which pro-
longs (pre-) B cell life span, does not rescue the maturation defects
in Btk-deficient 3-83 immature B cells in the BM, but does
restore the development of T2 B cells in the spleen.
Expression of the pre-BCR triggers IL-7-driven proliferative ex-
pansion, allelic exclusion, cellular maturation of pre-B cells, and
the initiation of L chain rearrangement (1, 2). We have previously
shown that Btk has an important function in the regulation of the
substantial changes in cell phenotype that accompanies pre-B cell
maturation, including down-regulation of SLC, CD43, and BP-1,
and up-regulation of CD2, CD25, and MHC class II (5, 8). How-
ever, the functional significance of the modulation of the individ-
ual surface markers at the pre-B cell stage is largely unknown, with
the exception of SLC. The down-regulation of SLC expression is
assumed to limit the capacity of pre-B cells to proliferate. Hence,
after several divisions, these cycling cells fall into a resting state
where L chain rearrangement is initiated. At this stage of B cell
development, Btk and SLP-65 have synergistic roles as tumor sup-
pressors to limit pre-B cell expansion, most likely by signaling the
down-regulation of SLC expression (8). Recent analyses of RNA
expression profiles identified a major change in gene expression at
the transition from cycling into resting pre-B cells, as1000 genes
were found with differential expression with a magnitude of 2
(37, 38). In flow cytometric analyses, we observed similar differ-
ences between Btk-deficient and WT B cells for surface and in-
tracellular expression of CD2, CD25, and MHC class II in c
pre-B cells (S.M. and R.W.H., unpublished results), indicating that
the absence of Btk affects the initiation of the expression of these
genes rather than transport of existing protein from cytoplasmic
stores to the cell surface. It is therefore possible that Btk is directly
or indirectly involved in the regulation of a substantial proportion
of the genes required for the initiation of new differentiation pro-
grams in resting pre-B cells.
In this context, we found that premature expression of the pre-
rearranged 3-83 BCR, which accelerates B cell development
(34, 39), is not completely able to replace pre-BCR function, as
cellular maturation in these mice was impaired, when compared
with non-Tg mice. Nevertheless, the aberrant phenotype of 3-83
immature B cells did not seem to significantly affect their capa-
bilities for further maturation in the spleen. In contrast, in the ab-
sence of Btk we found a much more defective modulation of
marker expression in the BM and a severe decrease in absolute B
cell numbers in the spleen, reflecting an almost complete arrest of
B cell development at the transition of T1 to T2 immature B cells
in the spleen. This contrasts with the arrest in non-Tg Btk-deficient
mice, which is at the next developmental transition from T2 into
mature B cells.
The cells generated in the BM of the Btk 3-83 mice were
shown to home into the spleen, even in the presence of competitive
Btk 3-83 B cells. In BrdU-labeling studies, we showed that the
FIGURE 6. Bcl-2 expression does not rescue developmental defects in
Btk-deficient non-Tg or 3-83 mice. A, BM B220lowIgM pro- and pre-B
cells of Btk and Btk Bcl-2 Tg mice were gated and expression of several
developmentally regulated markers is shown as histograms. Numbers in-
dicate percentage of cells positive for the indicated marker and plots are
representative for two to four mice of each genotype. B, BM B220lowIgM
immature B cells were gated and expression of Ig and BP-1 or CD2 is
shown. Numbers indicate percentage of BP-1- or CD2-positive cells within
 or  immature B cells. C, BM B220low cells of Btk and Btk
3-83/Bcl-2 double Tg mice were gated and analyzed for expression of
several developmentally regulated markers as shown in the histograms. D,
Splenic lymphoid cells were gated and analyzed for IgM/IgD expression
and for CD21/CD23 and 54-1/Ig expression profiles on B220 gated
cells. The percentages of cells within the indicated gates or quadrants are
given. Data represent three mice analyzed per genotype.
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numbers of B cells immigrating from the BM in the spleen within
24 h is similar in Btk and Btk 3-83 mice. However, Btk
3-83 B cells are efficiently deleted upon arrival in the spleen. It
is not likely that the elimination of Btk 3-83 B cells is due to
autoreactivity of the 3-83 BCR as 1) the deletion of B cells
takes place in the spleen and not in the BM; 2) immature B cells
in the BM did not manifest down-regulation of CD19 and IgM
surface expression; 3) most splenic B cells express the 3-83 Id
54-1, indicating that they did not perform receptor editing; and 4)
when the Btk 3-83 B cells were on a centrally deleting back-
ground, the induction of receptor editing even increased survival of
T2 peripheral B cells. Instead, our finding that the early T1 to T2
block could be restored by enforced Bcl-2 expression indicates that
Btk is required for the survival of T2 cells that carry the 3-83
BCR. Interestingly, 3-83 Tg and 3-83 Bcl-2 double Tg
Lyn/ B cells were also found to be arrested at the T1 and T2
immature B cell stage in the spleen, respectively (40), further sup-
porting synergistic roles for Lyn and Btk in peripheral B cell sur-
vival (41). In this respect, the function of CD45 and CD19 in
peripheral B cell survival appears to be different, as 3-83 Tg
CD45/ and CD19/ mice showed relatively mild defects in the
transitional B cell compartment in the spleen (39, 42, 43).
We have previously shown that lack of Btk did not abolish the
receptor editing competence of immature B cells (20). Surpris-
ingly, we found that when Btk-deficient 3-83 mice were crossed
onto a centrally deleting background and the B cells were targeted
for receptor editing, both the cellular maturation defects of imma-
ture B cells in the BM and the defective T1 to T2 transition of
splenic B cells are restored. It has been shown that B cells with an
autoreactive BCR are delayed for 2–12 h in the small pre-B cells
compartment where L chain rearrangements take place (17, 18).
This delay may provide an extended time window per cell, which
could be sufficient to compensate for the impaired cellular matu-
ration of Btk pre-B cells. Alternatively, it is also possible that
engagement of the BCR with membrane-bound autoantigens in-
duces distinct Btk-independent signaling pathways that drive cel-
lular maturation of editing immature B cells. However, enforced
expression of Bcl-2 did not improve cellular maturation of non-Tg
or 3-83 Btk-deficient immature B cells, indicating that increased
life span is not sufficient to correct the Btk-mediated pre-BCR
maturation signals. Therefore, our observations would be consis-
tent with the hypothesis that an autoreactive BCR undergoing re-
ceptor editing transmits an additional unique signal that enhances
cellular maturation of editing pre-B/immature B cells, next to the
signals required for the receptor editing events, such as expression
of the recombination-activating gene proteins. Such an additional
signal would not be provided by an innocuous BCR, as on a non-
deleting MHC class I background 3-83 immature B cells
showed defective cellular maturation. Additional experiments are
required to investigate whether BCR stimulated by autoantigens
indeed provide maturation signals for editing cells and whether
such signals affect the capacity of immature B cells to continue
receptor editing or their sensitivity to Ag-induced apoptosis (13).
In this context, the finding that in Btk-deficient mice  B cells
show a more profound cellular maturation defect than  B cells
may suggest that in these mice  B cells have performed exten-
sive receptor editing. This may be supported by our previous anal-
ysis of the kinetics of pre-B cell differentiation in vivo (5, 20). We
observed that in Btk-deficient mice,  B cells manifest a specific
developmental delay within the small pre-B cell compartment of
3 h, accompanied by a decreased production rate. Therefore, the
residual  B cell population in Btk-deficient mice may develop rel-
atively late and consequently contain more cells that have performed
receptor editing. Additional experiments are required to directly de-
termine the extent of receptor editing in Btk-deficient mice.
In conclusion, we have shown that in the absence of Btk 3-83
B cells are quite efficiently deleted during their development,
whether they are on a nondeleting background or on a centrally
deleting background. On the nondeleting background, the prema-
ture BCR expression amplifies the cellular maturation defects in
Btk-deficient immature B cells, finally resulting in defective sur-
vival at the T1 to T2 transition in the spleen. On the autoreactive
MHC class I background, most immature B cells are deleted in the
BM, but cellular maturation defects are significantly reduced and
edited B cells that reach the spleen no longer exhibit the T1 to T2
arrest. Our results suggest that at the immature B cell stage in the
BM, BCR stimulation by autoantigens does not only induce re-
ceptor editing, but also enhances cellular maturation.
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